Purchase Order W81K0024P0202
Award Date
10/1/24
Potential Completion Date
9/30/27
Potential Value
$538K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Cardinal Health 414, LLC
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,466.62 firm fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414 is a well-established provider of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and...
This federal contract award was issued by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $3,000.00 Firm Fixed Price contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an ultimate completion date of September...
This federal contract award, valued at $1,020,000.00, was issued by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of various radiopharmaceuticals, which are critical medical isotopes used in nuclear medicine and diagnostic imaging procedures. The contract is structured as a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. It has an ultimate completion date of September 30, 2025....
This is a federal contract award from the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, which are radioactive isotopes used in medical imaging and treatment. The contract has a ceiling value of $563,789.91 and a performance period through September 30, 2026. It is structured as a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation,...
This $955,499.55 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an...
This federal contract award, valued at $801,456.68, was issued by the Veterans Integrated Service Network 21 (VISN 21) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This delivery order contract has a...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the delivery of radiopharmaceutical supplies. The contract, valued at $358,406.52, was awarded by the Defense Health Agency (DHA) and has an ultimate completion date of October 1, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products...
This federal contract award, valued at $405,154.73, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products are delivered to VA medical...
This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA). The $145,418.67 fixed-price delivery order was transferred from a previous agency to DHA and has a completion date of September 30, 2021. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. Cardinal Health 414 is a prominent supplier of radiopharmaceuticals and specialized medical products to federal healthcare agencies,...
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceutical products. The $738,865.37 contract covers the period from October 1, 2021, to September 30, 2022, and supports the DHA's nuclear medicine and diagnostic imaging requirements. Cardinal Health 414, LLC is a prominent supplier of specialized medical isotopes and radiopharmaceutical therapies to federal...